Astegolimab (RG 6149) is a humanised IgG2 monoclonal antibody that targets the IL-33 receptor and inhibits IL-33 signalling. Astegolimab is used in the study of chronic obstructive pulmonary disease (COPD) and severe asthma in adults.
CAS Number:
[2173054-79-8]
Target:
Interleukin
* VAT and and shipping costs not included. Errors and price changes excepted